OXYGENTA PHARMACEUTICAL
Back to Cashflow Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Cash Flow from Investing Activities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Investing Activities | ₹-14 Cr | ₹-11 Cr | ₹-4.09 Cr | ₹-9.64 Cr | ₹-4.94 Cr |
What is the latest Cash Flow from Investing Activities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Cash Flow from Investing Activities |
|---|---|
| Mar2026 | ₹-14 Cr |
| Mar2025 | ₹-11 Cr |
| Mar2024 | ₹-4.09 Cr |
| Mar2023 | ₹-9.64 Cr |
| Mar2022 | ₹-4.94 Cr |
How is Cash Flow from Investing Activities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Cash Flow from Investing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-14 Cr | Negative | |
| Mar2025 | ₹-11 Cr | Negative | |
| Mar2024 | ₹-4.09 Cr | Negative | |
| Mar2023 | ₹-9.64 Cr | Negative | |
| Mar2022 | ₹-4.94 Cr | - | |
Compare Cash Flow from Investing Activities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹249.2 Cr | 25.7% | 37% | -31.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹466,155.0 Cr | -0.3% | -0.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 3.1% | 16.7% | 39.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,479.0 Cr | -1.5% | -2.8% | 38.7% | Stock Analytics | |
| CIPLA | ₹118,027.0 Cr | -0.8% | 1.6% | -1.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,662.0 Cr | 2.9% | -1.9% | 0.2% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 25.7% |
37% |
-31.1% |
| SENSEX | -1.1% |
1.3% |
-3.3% |
You may also like the below Video Courses